Proximity Proteomics Advances Spatial Proteome Profiling with Single-Cell-Type Resolution

Study Background and Research Question

Understanding how diverse cell types are spatially organized and interact within tissues is central to decoding both physiological processes and disease mechanisms. Traditional spatial proteomics—primarily via laser microdissection followed by mass spectrometry (LMD-MS) or multiplexed antibody-based imaging—has significantly advanced this field. However, these approaches often face trade-offs between spatial precision, throughput, and the depth of proteome coverage. In particular, the challenge of profiling the proteomes of individual cell types within intact tissue slices, without compromising spatial context, remains unresolved. Mao et al. (2025) address this gap by developing a proximity labeling-based workflow that enables comprehensive, spatially resolved proteome mapping at single-cell-type resolution.

Key Innovation from the Reference Study

The central innovation in this study is the introduction of PSPro (Proximity labeling for Spatial Proteomics), which integrates antibody-targeted proximity biotinylation with efficient affinity purification. This technique uniquely enables all-at-once capture of cell-type-specific proteomes directly from single tissue slices. By optimizing labeling conditions, the authors achieve high selectivity—enriching thousands of proteins from specific cell types—while maintaining sub-micrometer spatial resolution. Unlike traditional LMD-MS, which is limited by sampling scale and throughput, or antibody-based imaging, which is restricted in proteome depth, PSPro bridges these limitations, offering a scalable and accessible approach to spatial proteomics (Mao et al., 2025).

Methods and Experimental Design Insights

PSPro combines several critical methodological steps:

• Antibody-Targeted Proximity Labeling: Selected antibodies are used to direct biotinylation enzymes to the cell type of interest. The enzyme catalyzes the covalent labeling of nearby proteins, tagging them for subsequent enrichment.
• Optimized Labeling Parameters: The protocol involves fine-tuning the concentration of labeling reagents, incubation duration, and washing steps to maximize specificity and minimize background labeling. This is crucial for achieving single-cell-type selectivity within complex tissue environments.
• Affinity Purification: Biotinylated proteins are extracted and enriched using streptavidin affinity capture, allowing for downstream mass spectrometry-based proteome analysis.
• Integration with Laser Microdissection (LMD): For spatially resolving subpopulations within a tissue slice, PSPro can be combined with LMD, enabling the comparison of proteomes from distinct spatial regions or cell subsets in situ.

Benchmarking experiments were performed against conventional flow cytometry- and LMD-based workflows, validating the specificity and depth of proteome coverage achieved by PSPro.

Protocol Parameters

• Antibody incubation: Use highly specific, validated antibodies for cell-type selection. Incubate with tissue slices under optimized conditions (e.g., 1–2 hours at room temperature; follow antibody datasheet for ideal concentration).
• Biotinylation reagent application: Apply proximity labeling enzyme and biotinylation substrate at concentrations determined by prior titration (typically in the range of 0.1–1 μM); incubate for 10–30 min, monitoring for non-specific background.
• Stringent washing steps: Employ multiple washes with PBS or buffer containing mild detergent to remove unbound reagents and reduce off-target labeling.
• Affinity purification: Use streptavidin-conjugated beads to capture biotinylated proteins, followed by elution under denaturing conditions for MS analysis.
• Laser microdissection (optional): For spatial subpopulation analysis, perform LMD before or after proximity labeling, depending on experimental goals.

Core Findings and Why They Matter

Applying PSPro to murine pancreatic tumor and spleen slices, the authors successfully profiled the proteomes of ten distinct cell types in a single experiment. Thousands of proteins, including canonical cell-type markers, were enriched and identified. Importantly, by integrating LMD, PSPro enabled the comparison of spatially distinct subpopulations—such as cancer and immune cell subsets—within the same tissue slice. This revealed pronounced spatial heterogeneity in proteome composition, underscoring the complexity of cellular interactions in the tumor microenvironment (Mao et al., 2025).

These findings demonstrate that PSPro can convert the traditional "antibody-epitope" paradigm into an "antibody-cell-type proteome" approach, providing a powerful tool for spatial biology. The capacity to perform comprehensive, unbiased proteome profiling of defined cell types in situ is likely to accelerate biomarker discovery, therapeutic target validation, and the mechanistic study of tissue heterogeneity in both health and disease.

Comparison with Existing Internal Articles

The Cy3 TSA Fluorescence System Kit and related internal resources focus on ultrasensitive detection of proteins and nucleic acids in fixed tissues using tyramide signal amplification (TSA) chemistry. These TSA fluorescence kits—such as those reviewed at Bestatin and BGJ398—are optimized for fluorescence microscopy detection, enabling visualization of low-abundance biomolecules with high spatial precision. While these systems excel at single or multiplexed protein/nucleic acid detection and localization, PSPro extends the spatial biology toolkit by enabling global, unbiased cell-type-specific proteome capture and analysis within intact tissue slices.

Notably, both approaches rely on the principle of signal amplification in immunohistochemistry or immunocytochemistry—TSA methods via enzymatic fluorophore deposition, PSPro via enzyme-mediated biotinylation and affinity enrichment. TSA kits are particularly valuable for visualizing the presence and localization of defined targets, while PSPro is suited for comprehensive proteome discovery and hypothesis generation. In practice, researchers may apply TSA-based fluorescence amplification (such as the Cy3 TSA Fluorescence System Kit) to validate and visualize specific markers identified through proteomics workflows like PSPro.

Limitations and Transferability

Despite its advantages, the PSPro method is subject to several limitations:

• Antibody specificity and availability: Success depends on the availability of highly specific, validated antibodies for the cell types of interest. Cross-reactivity or insufficient labeling can affect selectivity.
• Proteome coverage: Although PSPro enriches thousands of proteins, detection is ultimately constrained by mass spectrometry sensitivity and the abundance of labeled targets.
• Sample preparation complexity: The protocol involves multiple steps—antibody incubation, labeling, washing, affinity purification—which can introduce variability. Stringent optimization is required for reproducibility across tissue types and experimental setups.
• Transferability: While demonstrated in murine tumor and spleen slices, adaptation to other tissues or organisms may require protocol refinement, particularly regarding tissue permeability and antibody performance.

Research Support Resources

For researchers aiming to visualize specific protein or nucleic acid targets identified through spatial proteomics, robust signal amplification strategies remain essential. The Cy3 TSA Fluorescence System Kit (SKU K1051) from APExBIO offers an effective means of enhancing detection sensitivity in immunohistochemistry, immunocytochemistry, and in situ hybridization. Utilizing horseradish peroxidase-catalyzed deposition of Cy3-tyramide, this kit enables detection of low-abundance biomolecules with high-density fluorescence, supporting workflows that require precise spatial localization of targets in fixed samples. For further details on the technical application of tyramide signal amplification in fluorescence microscopy, see the discussions at Cy7-Carboxylic Acid and KU-0063794.

By integrating advanced spatial proteomics with validated amplification kits, researchers can both discover novel cell-type-specific markers and visualize them with high sensitivity, closing the loop from global discovery to targeted validation in tissue biology studies.